G. Perona

1.9k total citations
68 papers, 1.6k citations indexed

About

G. Perona is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, G. Perona has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 15 papers in Pathology and Forensic Medicine and 15 papers in Hematology. Recurrent topics in G. Perona's work include Lymphoma Diagnosis and Treatment (13 papers), Selenium in Biological Systems (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). G. Perona is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Selenium in Biological Systems (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). G. Perona collaborates with scholars based in Italy, United Kingdom and Japan. G. Perona's co-authors include Gian Cesare Guidi, Giovanni Pizzolo, Marco Chilosi, Gianpietro Semenzato, Alberto Ambrosetti, G Todeschini, Dino Veneri, R. Cellerino, Renzo Schiavon and L Fiore-Donati and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

G. Perona

67 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Perona Italy 27 415 373 329 320 279 68 1.6k
Earl N. Metz United States 24 263 0.6× 333 0.9× 354 1.1× 293 0.9× 223 0.8× 43 1.8k
Teresa Paglieroni United States 29 334 0.8× 156 0.4× 605 1.8× 978 3.1× 143 0.5× 60 2.8k
L. W. Powell Australia 20 108 0.3× 376 1.0× 210 0.6× 386 1.2× 110 0.4× 58 2.3k
Mark Roest Netherlands 25 180 0.4× 57 0.2× 251 0.8× 555 1.7× 98 0.4× 65 1.9k
Carol A. Seymour United Kingdom 17 177 0.4× 69 0.2× 107 0.3× 188 0.6× 49 0.2× 50 1.5k
Nils U. Bang United States 30 230 0.6× 59 0.2× 219 0.7× 1.2k 3.7× 95 0.3× 90 2.6k
Vinod Raina India 20 95 0.2× 286 0.8× 154 0.5× 193 0.6× 645 2.3× 102 1.6k
Antonio Julià Spain 25 394 0.9× 144 0.4× 208 0.6× 348 1.1× 261 0.9× 73 2.1k
Masahiko Kaito Japan 29 162 0.4× 98 0.3× 258 0.8× 357 1.1× 242 0.9× 85 2.8k
Edward L. Krawitt United States 27 316 0.8× 174 0.5× 115 0.3× 129 0.4× 209 0.7× 63 4.8k

Countries citing papers authored by G. Perona

Since Specialization
Citations

This map shows the geographic impact of G. Perona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Perona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Perona more than expected).

Fields of papers citing papers by G. Perona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Perona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Perona. The network helps show where G. Perona may publish in the future.

Co-authorship network of co-authors of G. Perona

This figure shows the co-authorship network connecting the top 25 collaborators of G. Perona. A scholar is included among the top collaborators of G. Perona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Perona. G. Perona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bandini, Giuseppe, Elisa Zuffa, G. Rosti, et al.. (2008). Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years. British Journal of Haematology. 77(4). 486–490. 3 indexed citations
2.
Ambrosetti, Achille, Barbara Rossi, C. Vincenzi, et al.. (2000). Transplantation Potential of Peripheral Whole Blood Primed by VACOP-B Chemotherapy Plus Filgrastim (r-metHuG-CSF) in Patients with Aggressive Non-Hodgkin's Lymphoma. Journal of Hematotherapy & Stem Cell Research. 9(5). 673–682. 4 indexed citations
3.
Franchini, Massimo, Cristina Tecchio, Vittorio Meneghini, et al.. (1999). Improved prognosis of Pseudomonas aeruginosca bacteremia in 127 consecutive neutropenic patients with hematologic malignancies. International Journal of Infectious Diseases. 3(2). 99–104. 27 indexed citations
4.
Dammacco, Franco, Franco Silvestris, Gianluigi Castoldi, et al.. (1998). The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy. International Journal of Clinical & Laboratory Research. 28(2). 127–134. 38 indexed citations
5.
6.
Cazzadori, Angelo, Giovanni Di Perri, Roberto Luzzati, et al.. (1995). Transbronchial Biopsy in the Diagnosis of Pulmonary Infiltrates in Immunocompromised Patients. CHEST Journal. 107(1). 101–106. 77 indexed citations
7.
Ricetti, M. M., et al.. (1994). Selenium enhances glutathione peroxidase activity and prostacyclin release in cultured human endothelial cells. Biological Trace Element Research. 46(1-2). 113–123. 17 indexed citations
8.
Pasini, Felice, Antonio Santo, Gianluigi Cetto, et al.. (1994). Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE. European Journal of Cancer. 30(1). 33–36. 14 indexed citations
9.
Bellisola, G., et al.. (1992). Selenium and glutathione peroxidase variations induced by polyunsaturated fatty acids oral supplementation in humans. Clinica Chimica Acta. 205(1-2). 75–85. 28 indexed citations
10.
Resegotti, L, Umberto Vitolo, M Bertini, et al.. (1991). MACOP-B for advanced stage large cell lymphoma (DLCL). More is better?. 5. 86–89. 1 indexed citations
11.
Todeschini, G, Dino Veneri, S. Carlini, et al.. (1991). Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes. Hematological Oncology. 9(3). 137–146. 1 indexed citations
12.
Todeschini, G, Alberto Ambrosetti, Vittorio Meneghini, et al.. (1990). Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.. Journal of Clinical Oncology. 8(5). 804–808. 80 indexed citations
13.
Ambrosetti, Alberto, Gianpietro Semenzato, Manlio Prior, et al.. (1989). Serum levels of soluble interleukin‐2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk. British Journal of Haematology. 73(2). 181–186. 27 indexed citations
14.
Pizzolo, Giovanni, Livio Trentin, Fabrizio Vinante, et al.. (1988). Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission. British Journal of Cancer. 58(3). 368–372. 35 indexed citations
15.
Pizzolo, Giovanni, Alberto Ambrosetti, Gianpietro Semenzato, et al.. (1984). B cells in chronic lymphocytic leukaemia comparative analysis of blood and bone marrow. Annals of Hematology. 49(2). 69–73. 2 indexed citations
16.
Cetto, Gian Luigi, et al.. (1983). Empiric Therapy of Infections in Hematologic Malignancies: A Prospective, Randomized Trial. Tumori Journal. 69(2). 155–160. 3 indexed citations
17.
Frezza, M, et al.. (1973). Bilirubin 3H kinetic studies: pattern of normal,Gilbert's syndrome amd haemolitic patients. 20. 363–371. 3 indexed citations
18.
Magrini, Umberto, et al.. (1968). Mucopolysaccharidoses: autoradiographic study of sulphate‐35S uptake by cultured fibroblasts. Annals of Human Genetics. 31(3). 231–236. 6 indexed citations
19.
Perona, G., et al.. (1966). Fanconi-Anämie bei einem Erwachsenen. Annals of Hematology. 13(2). 90–99. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026